Literature DB >> 20633138

Neuromedin U is necessary for normal gastrointestinal motility and is regulated by serotonin.

Yoshiki Nakashima1, Takanori Ida, Takahiro Sato, Yuki Nakamura, Tomoko Takahashi, Kenji Mori, Mikiya Miyazato, Kenji Kangawa, Jingo Kusukawa, Masayasu Kojima.   

Abstract

Neuromedin U (NMU) was originally isolated from porcine spinal cord and shown to be distributed in numerous tissues, including the gastrointestinal tract. However, little is known about the role of NMU in the regulation of gastrointestinal functions. We established a radioimmunoassay system that is exceptionally specific for mouse NMU and found high NMU content in the gastrointestinal tract, particularly in the Auerbach's and Meissner's plexi, suggesting a possible role of NMU in gastrointestinal motility. NMU promoted small intestinal transit, and NMU deficiency resulted in lowered intestinal motility rate and diminished the effect of serotonin-induced defecation and diarrhea. These results indicate that NMU promotes intestinal transit and maintains intestinal homeostasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20633138     DOI: 10.1111/j.1749-6632.2010.05504.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  5 in total

1.  Differential effects of selective agonists of neuromedin U1 and U2 receptors in obese and diabetic mice.

Authors:  Hiroaki Nagai; Tomoko Kaisho; Kotaro Yokoyama; Tomoko Asakawa; Hisashi Fujita; Kouta Matsumiya; Jiro Noguchi; Kazue Tsuchimori; Naoki Nishizawa; Yoko Kanematsu-Yamaki; Katsuko Dote; Hiroshi Inooka; Jun-Ichi Sakamoto; Tetsuya Ohtaki; Taiji Asami; Shiro Takekawa
Journal:  Br J Pharmacol       Date:  2017-12-18       Impact factor: 8.739

2.  Pathway and network analysis of genes related to osteoporosis.

Authors:  Lin Guo; Jia Han; Hao Guo; Dongmei Lv; Yun Wang
Journal:  Mol Med Rep       Date:  2019-06-06       Impact factor: 2.952

Review 3.  Neuromedin U, a Key Molecule in Metabolic Disorders.

Authors:  Hitoshi Teranishi; Reiko Hanada
Journal:  Int J Mol Sci       Date:  2021-04-19       Impact factor: 5.923

4.  Stimulation of osteoclast formation by RANKL requires interferon regulatory factor-4 and is inhibited by simvastatin in a mouse model of bone loss.

Authors:  Yoshiki Nakashima; Tatsuji Haneji
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

5.  Epidermal Neuromedin U Attenuates IgE-Mediated Allergic Skin Inflammation.

Authors:  Yoshiko Mizukawa; Takaaki Doi; Yoshimi Yamazaki; Akihiko Kudo; Tetsuo Shiohara
Journal:  PLoS One       Date:  2016-07-27       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.